Zogenix submitted an sNDA to FDA for a capsule formulation of Zohydro ER hydrocodone bitartrate designed to deter abuse by injection or nasal administration. The company expects a decision by FDA in 1Q15. If the...

Zogenix said it plans to submit an sNDA to FDA by October for a next-generation of pain drug Zohydro ER hydrocodone capsules designed to make it more difficult to abuse by injection or nasal administration....

Top-line data from the double-blind, U.S. Phase III Study 3103 in about 623 patients with moderate to severe chronic low back pain showed that CEP-33237 met the primary endpoint of maintaining the improvement in weekly...

Massachusetts Gov. Deval Patrick said doctors are now required to check a patient's controlled-substance history through a statewide prescription monitoring program (PMP) prior to prescribing Zogenix's Zohydro ER hydrocodone bitartrate for pain drug. The program...

A judge in the U.S. District Court for the District of Massachusetts granted Zogenix's motion for a preliminary injunction thus stopping Massachusetts' statewide ban on Zogenix's pain drug Zohydro ER hydrocodone bitartrate. Zogenix said the...